Nicotine Dependence
📧 Sign up to get email alerts when something new happens for Nicotine Dependence.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2022-01-05FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for bupropion hydrochloride from Sun Pharmaceutical Industries, authorizing the generic product’s ma…
-
FDA approval · 2021-12-13FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
FDA approved ScieGen Pharmaceuticals' supplemental application for a sustained-release generic version of bupropion hydrochloride, with the …
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Adjunctive Mood Management for Telephone-based Smoking Cessation [NA]
Clinical trial update for adjunctive mood management in telephone-based smoking cessation completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-15Clinical Trial Update: Effects of Intranasal Oxytocin on Cigarette Smoking [Phase 4]
Phase 4 clinical trial assessing intranasal oxytocin for nicotine dependence and tobacco smoking has completed with results posted.
-
FDA approval · 2021-11-09FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex), a nicotine replacement therapy, submitted by Haleon US Holdings…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-10-15FDA Approved: TYRVAYA — Original Application (Oyster Point Pharma, Inc.)
FDA approved TYRVAYA (varenicline nasal spray) through an Original NDA from Oyster Point Pharma, establishing a nasal spray formulation for …
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Very Low-Nicotine Cigarettes in Smokers With SUD [Phase 2]
Phase 2 clinical trial evaluating very low-nicotine cigarettes in smokers with substance use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Adaptive Pharmacotherapy for Smoking Cessation [Phase 2]
Phase 2 trial update for adaptive pharmacotherapy in nicotine dependence has completed with posted results.
-
FDA approval · 2021-08-03FDA Approved: AMAZON BASIC CARE NICOTINE POLACRILEX — Original Application (Amazon.com Services LLC)
FDA approved a generic version of nicotine polacrilex lozenges under the Amazon Basic Care brand through an original ANDA. The medication is…
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: Nicotine Replacement Therapy in Nicotine-dependent Arrestees [Phase 4]
Phase 4 clinical trial update on nicotine replacement therapy for nicotine-dependent arrestees, completed.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Combining Varenicline and Naltrexone for Smoking Cessation [Phase 2]
Phase 2 clinical trial update on combining varenicline and naltrexone for nicotine dependence and alcohol use disorder; study completed with…
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers [Phase 4]
Phase 4 trial update on behavioral activation and varenicline for smoking cessation in depressed smokers; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Placebo-controlled Trial of Bupropion for Smoking Cessation in Pregnant Women [Phase 2]
Phase 2 placebo-controlled trial of bupropion for smoking cessation in pregnant women has completed with results posted.
-
FDA approval · 2021-04-23FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2021-04-23FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application to market NICORETTE 4 mg Fruit Chill Gum (nicotine polacrilex) by Lil' Drug Store Products, Inc.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Varenicline (Chantix) Treatment for Waterpipe Smoking Cessation [Phase 4]
Phase 4 trial evaluating varenicline (Chantix) for waterpipe smoking cessation in nicotine dependence.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Enhancing Self Regulation Among Smokers [Phase 2]
Phase 2 clinical trial update on enhancing self-regulation among smokers; study completed with results posted.
-
FDA approval · 2021-03-05FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nicorette nicotine polacrilex from Haleon US Holdings LLC.
-
FDA approval · 2021-01-04FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Bupropion Hydrochloride from Amneal Pharmaceuticals of New York LLC, authorizing the generic pro…
-
FDA approval · 2020-12-22FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Dr. Reddys Laboratories Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride SR, granting approval for the generic sustained-release formulation …
-
FDA approval · 2020-12-15FDA Approved: NICOTINE POLACRILEX — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for NICOTINE POLACRILEX from Dr. Reddy's Laboratories, confirming continued approval of this nicotin…
-
FDA approval · 2020-12-15FDA Approved: NICOTINE POLACRILEX — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA has approved a supplemental application for NICOTINE POLACRILEX from Dr. Reddy's Laboratories Inc.
-
FDA approval · 2020-12-15FDA Approved: NICOTINE POLACRILEX — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approved a supplemental application for NICOTINE POLACRILEX (nicotine polacrilex) from Dr. Reddy's Laboratories Inc., enabling continued…
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence [Phase 2, Phase 3]
Clinical trial update reporting completed Phase 2/Phase 3 human laboratory study of varenicline and bupropion for nicotine dependence and wi…
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Smoking, Sex Hormones, and Pregnancy [Phase 2]
Phase 2 clinical trial update on smoking, sex hormones, and pregnancy; results posted after completion.